薏苡附子散心血管保护与线粒体-内质网互作机制综述
心血管疾病仍是全球主要死因。本文综述薏苡附子散(YYFZ)及其组分薏苡仁与附子对心血管的保护作用,网络药理学提示其可能通过调控线粒体-内质网互作发挥作用;机制涉及调脂调糖、影响线粒体结构与功能、调节内质网应激、抑制氧化应激与炎症、调控细胞凋亡及维持钙离子平衡等通路,但尚需高质量实验研究进一步阐明。
要点
- YYFZ为《金匮要略》经典方,由薏苡仁与附子组成,历史上用于治疗多种心血管疾病。
- 网络药理学提示YYFZ可能直接或间接影响线粒体-内质网互作。
- 机制涉及调控心血管危险因素、线粒体功能、内质网应激、氧化应激、炎症、凋亡及钙平衡等多条通路。
核心结论
- YYFZ及其组分薏苡仁与附子具有心血管保护作用,其潜在机制与调控线粒体-内质网互作及相关信号通路有关。
研究设计与样本
- 本文为综述,聚焦薏苡仁与附子的心血管保护作用,并汇总YYFZ作用于线粒体与内质网的潜在机制。
主要发现
- YYFZ的机制涉及调节心血管危险因素(如血脂和血糖)、影响线粒体结构与功能、调节内质网应激、抑制氧化应激、抑制炎症反应、调控细胞凋亡及维持钙离子平衡。
关键数值与推荐
- 涉及的通路包括上调IGF-1/PI3K/AKT、cAMP/PKA、eNOS/NO/cGMP/SIRT1、SIRT1/PGC-1α、Klotho/SIRT1、OXPHOS/ATP、PPARα/PGC-1α/SIRT3、AMPK/JNK、PTEN/PI3K/AKT、β2-AR/PI3K/AKT及修饰的Q循环信号通路。
- MCU、NF-κB和JAK/STAT信号通路被下调。
- PERK/eIF2α/ATF4/CHOP、PERK/SREBP-1c/FAS、IRE1、PINK1依赖的线粒体自噬及AMPK/mTOR信号通路被双向调节。
临床怎么用
- 为中医与中西医结合医生理解YYFZ心血管保护作用的潜在分子机制提供参考,但临床应用仍需结合辨证并等待高质量实验证据支持。
局限性
- 需高质量实验研究进一步阐明YYFZ治疗心血管疾病的确切机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular diseases (CVD) remain the leading cause of death worldwide and represent a major public health challenge. YiyiFuzi Powder (YYFZ), composed of Coicis semen and Fuzi, is a classical traditional Chinese medicine prescription from the Synopsis of Golden Chamber dating back to the Han Dynasty. Historically, YYFZ has been used to treat various CVD, rooted in Chinese therapeutic principles. Network pharmacology analysis indicated that YYFZ may exhibit direct or indirect effects on mitochondria-endoplasmic reticulum (ER) interactions. This review, focusing on the cardiovascular protective effects of Coicis semen and Fuzi, summarizes the potential mechanisms by which YYFZ acts on mitochondria and the ER. The underlying mechanisms are associated with regulating cardiovascular risk factors (such as blood lipids and glucose), impacting mitochondrial structure and function, modulating ER stress, inhibiting oxidative stress, suppressing inflammatory responses, regulating cellular apoptosis, and maintaining calcium ion balance. The involved pathways include, but were not limited to, upregulating the IGF-1/PI3K/AKT, cAMP/PKA, eNOS/NO/cGMP/SIRT1, SIRT1/PGC-1α, Klotho/SIRT1, OXPHOS/ATP, PPARα/PGC-1α/SIRT3, AMPK/JNK, PTEN/PI3K/AKT, β2-AR/PI3K/AKT, and modified Q cycle signaling pathways. Meanwhile, the MCU, NF-κB, and JAK/STAT signaling pathways were downregulated. The PERK/eIF2α/ATF4/CHOP, PERK/SREBP-1c/FAS, IRE1, PINK1-dependent mitophagy, and AMPK/mTOR signaling pathways were bidirectionally regulated. High-quality experimental studies are needed to further elucidate the underlying mechanisms of YYFZ in CVD treatment.
引用
- Ding J, Ji R, Wang Z, et al. Cardiovascular protection of YiyiFuzi powder and the potential mechanisms through modulating mitochondria-endoplasmic reticulum interactions. Front Pharmacol. 2024. PMID: 38978978. doi:10.3389/fphar.2024.1405545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。